Spero Therapeutics, Inc. (SPRO) › Net IncomeSpero Therapeutics, Inc. (SPRO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$13.15M2016: -$32.64M2017: -$39.89M2018: -$41.66M2019: -$60.92M2020: -$78.28M2021: -$89.76M2022: -$46.41M2023: $22.81M2024: -$68.57M2025: $8.57M$8.57M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$8.57M+112.5%2024-$68.57M-400.6%2023$22.81M+149.1%2022-$46.41M+48.3%2021-$89.76M-14.7%2020-$78.28M-28.5%2019-$60.92M-46.2%2018-$41.66M-4.5%2017-$39.89M-22.2%2016-$32.64M-148.2%2015-$13.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share